A new study by The Scripps Research Institute and Hong Kong University determined the crystal structure of CR3022, a neutralizing antibody previously isolated from a convalescent SARS patient
The outbreak of COVID-19 caused by SARS-CoV-2 virus has now become a pandemic, but there is currently very little understanding of the antigenicity of the virus. Source Science A recent study has shown that CR3022 can also bind to the RBD of SARS-CoV-2 . This finding provides an opportunity to uncover a cross-reactive epitope. Therefore